FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -50.0% | 360 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 360 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | -50.0% | 360 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 360 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -11.1% | 360 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 360 | +29.0% | 0.00% | – |
| Q1 2022 | $11,000 | -31.2% | 279 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -15.8% | 279 | -14.4% | 0.00% | – |
| Q3 2021 | $19,000 | +18.8% | 326 | +75.3% | 0.00% | – |
| Q2 2021 | $16,000 | +6.7% | 186 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | 0.0% | 186 | +13.4% | 0.00% | – |
| Q4 2020 | $15,000 | -25.0% | 164 | -66.5% | 0.00% | – |
| Q3 2020 | $20,000 | +122.2% | 490 | +19.5% | 0.00% | – |
| Q2 2020 | $9,000 | 0.0% | 410 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | +12.5% | 410 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +33.3% | 410 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 410 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | +14.3% | 410 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | 0.0% | 410 | -25.5% | 0.00% | – |
| Q4 2018 | $7,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |